Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents

To determine the efficacy and safety of atomoxetine in the treatment of ADHD in children and adolescents.

This is a protocol.

Health topics:

Developmental, psychosocial & learning problems > Psychosocial problems > Attention deficit hyperactivity disorder (ADHD)

Published:

18 April 2012

Authors:

Kallapiran GK, Mammen P, Tharyan P, Russell P

Primary Review Group:

Developmental, Psychosocial and Learning Problems Group

See the full Review on

the Cochrane Library

►

Print
PDF
Citation
Kallapiran GK, Mammen P, Tharyan P, Russell P. Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD009804. DOI: 10.1002/14651858.CD009804

Don't show again

What role do you identify with the most?

General public, patient, or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.